îæ€çŽ¢
îæ€çŽ¢
î
4D Molecular Therapeutics Inc
FDMTîãŠã©ãããªã¹ãã«è¿œå
9.660USD
+0.240+2.55%
çµå€Â 06/18, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
504.94Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-06-184D Molecular Therapeutics Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.18ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯389瀟äž156äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯33.00ã§ãæé«ã¯45.00ãæäœã¯17.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
11
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
28.222
ç®æšæ ªäŸ¡
+192.16%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
560
åèš
5
äžå€®å€
6
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
4D Molecular Therapeutics Inc
FDMT
11
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
å 責äºé ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
ãããã質å
4D Molecular Therapeutics Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
î4D Molecular Therapeutics Inc ã®äºæ³åç㯠8.00M ã§ãã
4D Molecular Therapeutics Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ã4D Molecular Therapeutics Inc ã®ç®æšæ ªäŸ¡ã USD 33.00 ãšäºæ³ããæé«äºæ³ã¯ USD 45.00ãæäœäºæ³ã¯ USD 17.00 ãšäºæ³ããŠããŸãã
4D Molecular Therapeutics IncFDMT ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -1.01 ã§ãããã4D Molecular Therapeutics IncFDMT ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 0.30 ã§ããã次ã®ååæã® EPS 㯠USD -0.87 ãšäºæ³ãããŸãã
4D Molecular Therapeutics Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î11 ã¢ããªã¹ãã«ãã 4D Molecular Therapeutics Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« 4D Molecular Therapeutics Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã
